The expansion doubles BGG’s astaxanthin production capacity and will allow for fulfillment of customers’ demands for the next 3-5 years, after which adjacent land will be utilized for future expansions.
“At BGG, we never want to leave any customer with unfulfilled or late orders, and we rarely do,” said Chunhua Li, Chairman & Founder of BGG World, in the press release. “This expansion of capacity for our flagship AstaZine Natural Astaxanthin product line should keep our customers happy and their orders filled into the second half of this decade.”
Related: Formula Shown to Support Eye Health in Human Clinical Study AstaReal Patent Supports Use for Gut Microbiome Support Tocotrienol, Astaxanthin Combo Shows Promise in Cognitive Health Study
BGG Americas and Algae Health Sciences CEO Bob Capelli added: “We not only continue to lead the Astaxanthin market with ongoing clinical research, but we back that up with capacity expansions to consistently stay ahead of demand. Having worked in the Astaxanthin business for the last twenty years, I’ve never seen any producer react as quickly to market needs.”